a provider of therapeutic antibodies for inflammation and immuno-oncology
Industry Biotechnology
A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with ADCT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then ADCT could also see price increases.
Ticker / NAME | Correlation To ANAB | 1D Price Change % | ||
---|---|---|---|---|
ANAB | 100% | +6.80% | ||
ADCT - ANAB | 40% Loosely correlated | +5.82% | ||
HRMY - ANAB | 40% Loosely correlated | +2.07% | ||
SAGE - ANAB | 38% Loosely correlated | -0.74% | ||
SLRN - ANAB | 36% Loosely correlated | +4.33% | ||
AURA - ANAB | 35% Loosely correlated | +5.71% | ||
More |